1. A missense mutation in TRAPPC6A leads to build-up of the protein, in patients with a neurodevelopmental syndrome and dysmorphic features
- Author
-
Kay Childs, Saleem Ahmed, Hussein Sheikh Ali Mohamoud, Jumana Y. Al-Aama, Musharraf Jelani, Steve Goodbourn, Jamal Nasir, Nirmal Vadgama, Mona Mohammad Almramhi, and Nuha Alrayes
- Subjects
Male ,0301 basic medicine ,Candidate gene ,Developmental Disabilities ,Science ,Mutation, Missense ,Vesicular Transport Proteins ,Article ,03 medical and health sciences ,0302 clinical medicine ,Intellectual disability ,medicine ,Humans ,Missense mutation ,Child ,Exome sequencing ,Genetics ,Multidisciplinary ,TRAPPC2 ,biology ,Polydactyly ,Protein Stability ,Syndrome ,medicine.disease ,HEK293 Cells ,030104 developmental biology ,TRAPP complex ,Speech delay ,biology.protein ,Medicine ,Female ,medicine.symptom ,030217 neurology & neurosurgery - Abstract
Childhood onset clinical syndromes involving intellectual disability and dysmorphic features, such as polydactyly, suggest common developmental pathways link seemingly unrelated phenotypes. We identified a consanguineous family of Saudi origin with varying complex features including intellectual disability, speech delay, facial dysmorphism and polydactyly. Combining, microarray based comparative genomic hybridisation (CGH) to identify regions of homozygosity, with exome sequencing, led to the identification of homozygous mutations in five candidate genes (RSPH6A, ANKK1, AMOTL1, ALKBH8, TRAPPC6A), all of which appear to be pathogenic as predicted by Proven, SIFT and PolyPhen2 and segregate perfectly with the disease phenotype. We therefore looked for differences in expression levels of each protein in HEK293 cells, expressing either the wild-type or mutant full-length cDNA construct. Unexpectedly, wild-type TRAPPC6A appeared to be unstable, but addition of the proteasome inhibitor MG132 stabilised its expression. Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay. TRAPPC6A joins a growing list of proteins belonging to the TRAPP complex, implicated in clinical syndromes with neurodevelopmental abnormalities.
- Published
- 2018